Atlas Trials

Sulfasalazine for the Treatment of Primary Sclerosing Cholangitis

Clinical trial NCT03561584 · COMPLETED

Trial details

NCT number
NCT03561584
Sponsor
Brigham and Women's Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Primary Sclerosing Cholangitis
Start date
2018-07-01
Primary completion
2026-03-03
Enrollment
32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.